Control of atrial defibrillation therapy based on hemodynamic sensor feedback
US7336994B2 · kind B2 · utility
122Cited by
4References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 2004 |
| Grant date | Feb 26, 2008 |
| Priority date | — |
| Expiry date | Sep 12, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/395
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Control of defibrillation therapy delivered by implantable medical devices (IMDs) using hemodynamic sensor feedback is disclosed. The hemodynamic sensor feedback allows for increased control over application of atrial defibrillation therapy. Specifically, the therapy is delivered when a fibrillation episode results in a discrete loss of hemodynamic function. Defibrillation therapy is thus withheld for hemodynamically benign arrhythmias.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.